Anti-proliferative therapy for HIV cure: a compound interest approach
Abstract In the era of antiretroviral therapy (ART), HIV-1 infection is no longer tantamount to early death. Yet the benefits of treatment are available only to those who can access, afford, and tolerate taking daily pills. True cure is challenged by HIV latency, the ability of chromosomally integra...
Enregistré dans:
Auteurs principaux: | Daniel B. Reeves, Elizabeth R. Duke, Sean M. Hughes, Martin Prlic, Florian Hladik, Joshua T. Schiffer |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3bd56a0f58ac4f5799ab988ad7daaffa |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation
par: Daniel B. Reeves, et autres
Publié: (2018) -
Can a topical microbicide prevent rectal HIV transmission?
par: Florian Hladik, et autres
Publié: (2008) -
Nonhuman primate models for HIV cure research.
par: Cristian Apetrei, et autres
Publié: (2012) -
Editorial: Novel Insights Into a Functional HIV Cure
par: Luca Sardo, et autres
Publié: (2021) -
Proliferative diabetic retinopathy transcriptomes reveal angiogenesis, anti-angiogenic therapy escape mechanisms, fibrosis and lymphatic involvement
par: Ani Korhonen, et autres
Publié: (2021)